178 related articles for article (PubMed ID: 36967458)
21. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
Liu ZW; Zhou FJ; Han H; Qin ZK; Yu SL; Li YH; Ye YL; Teng XY
Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
[TBL] [Abstract][Full Text] [Related]
22. Testicular carcinoma.
O'Callaghan A; Mead GM
Postgrad Med J; 1997 Aug; 73(862):481-6. PubMed ID: 9307739
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in the biology of germ cell tumors: implications for the diagnosis and treatment.
Chieffi P; Chieffi S; Franco R; Sinisi AA
J Endocrinol Invest; 2012 Dec; 35(11):1015-20. PubMed ID: 23143673
[TBL] [Abstract][Full Text] [Related]
24. French AFU Cancer Committee Guidelines - Update 2022-2024: testicular germ cell cancer.
Murez T; Fléchon A; Branger N; Savoie PH; Rocher L; Camparo P; Neuville P; Ferretti L; Van Hove A; Roupret M
Prog Urol; 2022 Nov; 32(15):1066-1101. PubMed ID: 36400478
[TBL] [Abstract][Full Text] [Related]
25. The present and future of serum diagnostic tests for testicular germ cell tumours.
Murray MJ; Huddart RA; Coleman N
Nat Rev Urol; 2016 Dec; 13(12):715-725. PubMed ID: 27754472
[TBL] [Abstract][Full Text] [Related]
26. Chemotherapy-induced toxicity in patients with testicular germ cell tumors: The impact of physical fitness and regular exercise.
Amiri A; Chovanec M; Oliva V; Sedliak M; Mego M; Ukropec J; Ukropcová B
Andrology; 2021 Nov; 9(6):1879-1892. PubMed ID: 34245663
[TBL] [Abstract][Full Text] [Related]
27. Advances in diagnosis and treatment of testicular cancer.
Chovanec M; Cheng L
BMJ; 2022 Nov; 379():e070499. PubMed ID: 36442868
[TBL] [Abstract][Full Text] [Related]
28. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer.
Heidenreich A; Paffenholz P; Nestler T; Pfister D
Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568
[TBL] [Abstract][Full Text] [Related]
29. Emerging Role of Biomarkers in Testicular Germ Cell Tumors.
Soleimani M; Kollmannsberger C; Nappi L
Curr Oncol Rep; 2022 Apr; 24(4):437-442. PubMed ID: 35142973
[TBL] [Abstract][Full Text] [Related]
30. Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: a proof of principle.
Gillis AJ; Rijlaarsdam MA; Eini R; Dorssers LC; Biermann K; Murray MJ; Nicholson JC; Coleman N; Dieckmann KP; Belge G; Bullerdiek J; Xu T; Bernard N; Looijenga LH
Mol Oncol; 2013 Dec; 7(6):1083-92. PubMed ID: 24012110
[TBL] [Abstract][Full Text] [Related]
31. Molecular biomarkers as potential targets for therapeutic strategies in human testicular germ cell tumors: an overview.
Chieffi P; Chieffi S
J Cell Physiol; 2013 Aug; 228(8):1641-6. PubMed ID: 23359388
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of c-kit (CD 117) expression as a prognostic factor in testicular germ cell tumors: an Izmir Oncology Group (IZOG) study.
Salman T; Yildiz E; Yildiz I; Yavuzer D; Unlu M; Varol U; Akyol M; Yildiz Y; Bayoglu V; Kucukzeybek Y; Alacacioglu A
J BUON; 2015; 20(4):1054-60. PubMed ID: 26416056
[TBL] [Abstract][Full Text] [Related]
33. miR-371a-3p, miR-373-3p and miR-367-3p as Serum Biomarkers in Metastatic Testicular Germ Cell Cancers Before, During and After Chemotherapy.
Rosas Plaza X; van Agthoven T; Meijer C; van Vugt MATM; de Jong S; Gietema JA; Looijenga LHJ
Cells; 2019 Oct; 8(10):. PubMed ID: 31597402
[TBL] [Abstract][Full Text] [Related]
34. Testicular germ cell tumors: biology and clinical update.
Nallu A; Mannuel HD; Hussain A
Curr Opin Oncol; 2013 May; 25(3):266-72. PubMed ID: 23549473
[TBL] [Abstract][Full Text] [Related]
35. [CCAFU french national guidelines 2016-2018 on testicular germ cell tumors].
Durand X; Fléchon A; Murez T; Rocher L; Camparo P; Morel-Journel N; Savoie PH; Ferretti L; Sèbe P; Méjean A
Prog Urol; 2016 Nov; 27 Suppl 1():S147-S165. PubMed ID: 27846929
[TBL] [Abstract][Full Text] [Related]
36. Will Testicular Germ Cell Tumors Remain Untargetable?
Aoun F; Kourie HR; Albisinni S; Roumeguère T
Target Oncol; 2016 Dec; 11(6):711-721. PubMed ID: 27184492
[TBL] [Abstract][Full Text] [Related]
37. Germ Cell Testicular Tumors-Contemporary Diagnosis, Staging and Management of Localized and Advanced disease.
Goldberg H; Klaassen Z; Chandrasekar T; Fleshner N; Hamilton RJ; Jewett MAS
Urology; 2019 Mar; 125():8-19. PubMed ID: 30597167
[TBL] [Abstract][Full Text] [Related]
38. Cost Analysis of Noninvasive Blood-Based MicroRNA Testing Versus CT Scans for Follow-up in Patients With Testicular Germ-Cell Tumors.
Charytonowicz D; Aubrey H; Bell C; Ferret M; Tsui K; Atfield R; Coleman N; Murray MJ; Wilson ECF
Clin Genitourin Cancer; 2019 Aug; 17(4):e733-e744. PubMed ID: 31155478
[TBL] [Abstract][Full Text] [Related]
39. Cancer Stem Cell Niche and Immune-Active Tumor Microenvironment in Testicular Germ Cell Tumors.
Kalavska K; Kucerova L; Schmidtova S; Chovanec M; Mego M
Adv Exp Med Biol; 2020; 1226():111-121. PubMed ID: 32030680
[TBL] [Abstract][Full Text] [Related]
40. Molecular and cell biology of testicular germ cell tumors.
Chieffi P; Franco R; Portella G
Int Rev Cell Mol Biol; 2009; 278():277-308. PubMed ID: 19815181
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
